CSIMarket
 

Pacific Booker Minerals Inc   (PBM)
Other Ticker:  
 
    Sector  Basic Materials    Industry Metal Mining
   Industry Metal Mining
   Sector  Basic Materials

Pacific Booker Minerals Inc 's

Competitiveness


 

PBM Sales vs. its Competitors Q4 2022







Revenue Growth Comparisons




Net Income Comparison




<<  PBM Stock Performance Comparisons



*Market share is calculated based on total revenue.

  News about Pacific Booker Minerals Inc Contracts

Nature's Medicinal Magic: Unveiling the Therapeutic Superiority of Nature-Derived Psilocybin

In a breakthrough study published in the renowned journal Molecular Psychiatry, the comparative therapeutic benefits of nature-derived psilocybin and its synthetic counterpart have been explored. Through meticulous research, this study by Psyence Biomedical sheds light on the potential superiority of psilocybin derived from nature, providing a fascinating insight into the potential future of mental health treatment.Analysis of the Study:The study conducted by Psyence Biomedical delves into the profound effects of nature-derived psilocybin, suggesting its notable therapeutic advantages over synthetic alternatives. Researchers have meticulously compared the efficacy of both forms of psilocybin in addressing va...

Psyence Biomedical Granted Approval for Phase IIb Study on Psilocybin Treatment for Adjustment Disorder in Cancer Patients

Psyence Group Inc. (CSE: PSYG), a leading clinical-stage life science biotechnology company specializing in the use of nature-derived psilocybin for mental health and wellbeing, is pleased to announce that its associate, Psyence Biomedical Ltd (NASDAQ: PBM), has received full approval from the Australian Health Research Ethics Committee (HREC) to initiate a Phase IIb study. The study, which will be conducted in Melbourne, Australia, aims to investigate the efficacy of nature-derived psilocybin as a treatment for Adjustment Disorder in patients recently diagnosed with cancer in the palliative care context.According to a press release issued by PBM on March 6, 2024, a significant number of the estimated 56.8 ...

Psyence Group's Spin-Out Marks Major Milestone in Psychedelic Medicine Industry

Psyence Group, a leading innovator in the field of psychedelic medicine, recently provided a corporate update following the successful spin-out of its therapeutic division. The company closed the business combination of its subsidiary, Psyence Biomedical Ltd (PBM), with Newcourt Acquisition Corp, a special purpose acquisition company, ultimately resulting in the listing of PBM on the NASDAQ stock exchange.This strategic move by Psyence Group signifies its commitment to advancing the field of psychedelic medicine and capitalizing on the growing interest in this emerging industry. The spin-out of its therapeutic division allows the company to focus on its core areas of expertise, including the development of i...

Psyence Australia Receives HREC Approval for Phase IIb Study on Psilocybin's Efficacy in Palliative Care

Psyence Biomedicals Subsidiary, Psyence Australia, Receives Human Research Ethics Committee (HREC) Approval to Initiate Phase IIb StudyNEW YORK, March 06, 2024 - Psyence Biomedical Ltd (NASDAQ:PBM) (Psyence Biomed or the Company) is excited to announce a significant achievement for its wholly-owned subsidiary, Psyence Australia (Pty) Ltd (Psyence Australia). The Australian Health Research Ethics Committee (HREC) has granted full approval for Psyence Australia to commence its anticipated Phase IIb study in Melbourne, Australia. This ground-breaking study aims to investigate the potential use of nature-derived psilocybin as a treatment for Adjustment Disorder in individuals experiencing distress after a recent...





Who are Pacific Booker Minerals Inc 's Competitors?





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com